Mar 9, 2026 08:00AM

Mar 9, 2026 08:00AM

Nov 10, 2025 07:00AM

Nov 6, 2025 04:30PM

Aug 5, 2025 04:15PM

May 8, 2025 04:30PM

Mar 19, 2025 04:45PM Galecto Reports Full-Year 2024 Financial Results

Aug 15, 2023 07:32AM

Aug 15, 2023 07:30AM

Jul 31, 2023 04:05PM

May 23, 2023 08:30AM

Apr 26, 2022 08:30AM

Aug 5, 2021 08:30AM

Jul 13, 2021 08:09AM Galecto (GLTO) Resumes Recruitment in Phase 2b Global GALACTIC-1 Trial of GB0139 for Idiopathic Pulmonary Fibrosis

Jul 13, 2021 08:00AM

Jun 2, 2021 08:00AM

Jun 2, 2021 08:00AM

Mar 29, 2021 08:30AM

Mar 29, 2021 08:30AM

Mar 23, 2021 10:26AM

Mar 23, 2021 10:26AM UPDATE: Galecto Hosting Expert Perspective Panel on the Evolving Treatment Landscape for Idiopathic Pulmonary Fibrosis and Potential for GB0139

Mar 23, 2021 08:30AM

Mar 23, 2021 08:30AM

Mar 15, 2021 07:36AM

Mar 15, 2021 07:30AM

Mar 15, 2021 07:30AM

Dec 11, 2020 08:06AM

Nov 30, 2020 08:04AM Galecto Inc. (GLTO) Reports Publication of GB0139 Phase 2A Idiopathic Pulmonary Fibrosis

Nov 30, 2020 08:00AM

322,220 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All